PUBLISHER: The Business Research Company | PRODUCT CODE: 1949669
PUBLISHER: The Business Research Company | PRODUCT CODE: 1949669
Pharmaceutical excipients are components of a drug delivery system that are not active pharmaceutical ingredients (APIs) but have passed safety evaluations. Although they are not pharmacologically active, excipients enable the proper administration of the drug and support its intended mode and site of action.
The main types of pharmaceutical excipients include inorganic chemicals, organic chemicals, and others. The inorganic chemical sector focuses on the production, physical and chemical properties, assay techniques, and applications of inorganic substances used as pharmaceutical aids, treatments, and diagnostics. Excipients serve various functions, including fillers and diluents, suspending and viscosity agents, coating agents, flavoring agents, sweeteners, disintegrants, colorants, lubricants, glidants, and others. They are incorporated into multiple formulations, such as oral, topical, and parenteral preparations.
Tariffs have affected the pharmaceutical excipients market by increasing the cost of imported raw materials and chemicals, thereby impacting production expenses and supply chain efficiency. Segments such as organic chemicals and natural excipients, especially in regions like North America and Europe, are most affected due to high reliance on imports. However, tariffs have also encouraged local sourcing and domestic manufacturing, which may drive innovation and reduce dependency on international suppliers, creating potential long-term benefits for market players.
The pharmaceutical excipients market research report is one of a series of new reports from The Business Research Company that provides pharmaceutical excipients market statistics, including pharmaceutical excipients industry global market size, regional shares, competitors with a pharmaceutical excipients market share, detailed pharmaceutical excipients market segments, market trends and opportunities, and any further data you may need to thrive in the pharmaceutical excipients industry. This pharmaceutical excipients market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The pharmaceutical excipients market size has grown strongly in recent years. It will grow from $10822.05 billion in 2025 to $11529.87 billion in 2026 at a compound annual growth rate (CAGR) of 6.5%. The growth in the historic period can be attributed to increasing demand for oral formulations, growing pharmaceutical manufacturing in apac, adoption of synthetic excipients, stringent regulatory approvals, rising r&d in drug formulation.
The pharmaceutical excipients market size is expected to see strong growth in the next few years. It will grow to $14867 billion in 2030 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to growth in personalized medicine, surge in biopharmaceutical production, demand for natural and clean-label excipients, technological advancements in excipient synthesis, expansion of contract manufacturing organizations (cmos). Major trends in the forecast period include novel excipient formulations, enhanced drug stability solutions, targeted drug delivery systems, natural and plant-based excipients, multi-functional excipients.
The rise in biologics sales is expected to drive the growth of the pharmaceutical excipients market. Biologics, or biological products, are medicines derived from living organisms and include vaccines, blood and blood components, allergenics, somatic cells, gene therapies, tissues, and recombinant therapeutic proteins. Pharmaceutical excipients are critical in biologics, enhancing stability, improving formulation, and ensuring optimal delivery of active biological agents. For instance, in October 2024, according to the Generics and Biosimilars Initiative, a Belgium-based organization providing scientific information on generic and biosimilar medicines, beyond the nine leading biologics, two additional complex drugs achieved substantial sales in 2023. Novo Nordisk's Ozempic (semaglutide) and Eli Lilly's Trulicity (dulaglutide), both prescribed for type 2 diabetes, generated sales of US$14 billion and US$7.2 billion, respectively. Therefore, the increasing sales of biologics are propelling demand for pharmaceutical excipients.
Key companies in the pharmaceutical excipients market are introducing advanced excipients, such as high-purity excipients, to enhance drug formulation stability, improve bioavailability, and support complex drug delivery systems. High-purity excipients are ingredients that undergo advanced purification processes to remove impurities and contaminants, ensuring safety and performance in sensitive formulations. For instance, in October 2023, Clariant, a Switzerland-based specialty chemical company, launched three new VitiPure excipients designed to improve the stability and solubility of active pharmaceutical ingredients (APIs). These include VitiPure O 80 Superior (high-purity polysorbate 80), VitiPure CO 35 Superior (polyoxyl 35 castor oil), and VitiPure Meglumine LEX (a low-bioburden solubilizer). These excipients are tailored for complex drug delivery applications, including mRNA vaccines and biologics, addressing the growing need for high-purity ingredients while meeting stringent regulatory standards.
In March 2024, Roquette, a France-based producer of plant-based ingredients and pharmaceutical excipients, acquired IFF Pharma Solutions for $2.85 billion. This acquisition strengthens Roquette's position as a preferred partner in the pharmaceutical industry, enabling it to meet evolving customer needs and improve patient outcomes through enhanced treatment options. IFF Pharma Solutions, a US-based company, specializes in producing pharmaceutical excipients and specialty solutions for the pharmaceutical sector.
Major companies operating in the pharmaceutical excipients market are BASF SE, Ashland Global Holdings, Evonik Industries AG, International Flavors & Fragrances Inc, Roquette Freres, Archer Daniels Midland Company, Lubrizol Corporation, Croda International Plc, Kerry Group, DuPont de Nemours Inc., Amster Microcell Private Limited, Finar Limited, P. D. Polychem Private Limited, CAD Pharma Inc, Maas Pharma Chemicals, Aeon Procare Private Limited, CSPC Pharmaceutical Group Ltd, Allen & Hanburys Ltd, Colorcon, MEGGLE GmbH & Co. KG, DMV-Fonterra Excipients GmbH & Co. KG, Alpen Pharma AG, Avantor Inc, JRS PHARMA GmbH & Co. KG, The Dow Chemical Co, EMS Pharma, Biolab Farmaceutica, Medist FZE, W.R. Grace, Univar Solutions, Nitika Pharma, DFE Pharma, Cargill, Sensient Pharma
North America is the largest region in the pharmaceutical excipients market in 2025. Middle East is expected to be the fastest growing region in the global pharmaceutical excipients market share during the forecast period. The regions covered in the pharmaceutical excipients market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the pharmaceutical excipients market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The pharmaceutical excipients market consists of sales of microcrystalline cellulose, stearic acid, gelatin, and tartaric acid. Values in this market are factory gate values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Pharmaceutical Excipients Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses pharmaceutical excipients market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for pharmaceutical excipients ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The pharmaceutical excipients market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.